• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞慢性淋巴细胞白血病的并发症及死亡原因:105例患者的长期研究

Complications and causes of death in B cell chronic lymphocytic leukaemia: a long term study of 105 patients.

作者信息

Robertson T I

机构信息

Westmead Hospital, NSW, Australia.

出版信息

Aust N Z J Med. 1990 Feb;20(1):44-50. doi: 10.1111/j.1445-5994.1990.tb00370.x.

DOI:10.1111/j.1445-5994.1990.tb00370.x
PMID:2322201
Abstract

The complications and causes of death of 105 patients with B cell chronic lymphocytic leukaemia followed for a median period of 5.5 years are described. Infection and secondary primary malignant tumours were the most common complications and also caused most deaths. S. pneumoniae, S. aureus, S. haemolyticus, E. coli and the zoster-varicella virus accounted for most infections and the lungs, skin and urinary tract were the sites affected. Even trivial infections were potentially serious. Haemolytic anaemia and vascular complications were also common. Older patients tended to have a shorter survival than the mean for the group whereas younger patients fared better. The mean survival was 6.2 years. Analysis confirmed the prognostic value of Rai staging. Advancing disease increased the liability to major infection. Light bone marrow infiltration five years post diagnosis indicated a good prognosis and preservation of normal immunoglobulin levels seemed beneficial. Immunoglobulin deficiency is the factor that correlates best with the frequency, severity and pattern of infection. Early stage disease provides a distinct benefit and there may be advantages in prompt diagnosis, regular assessment by immunoglobulin levels and bone marrow pattern and treatment on the first evidence of advancing disease. Fresh symptoms should be investigated in their own right because of the likelihood of second tumours.

摘要

本文描述了105例B细胞慢性淋巴细胞白血病患者的并发症和死亡原因,这些患者的中位随访时间为5.5年。感染和继发性原发性恶性肿瘤是最常见的并发症,也是导致死亡的主要原因。肺炎链球菌、金黄色葡萄球菌、溶血葡萄球菌、大肠杆菌和带状疱疹-水痘病毒是大多数感染的病原体,感染部位主要是肺部、皮肤和泌尿系统。即使是轻微感染也可能很严重。溶血性贫血和血管并发症也很常见。老年患者的生存期往往短于该组的平均生存期,而年轻患者的情况较好。平均生存期为6.2年。分析证实了Rai分期的预后价值。疾病进展增加了发生严重感染的可能性。诊断后五年骨髓轻度浸润表明预后良好,维持正常免疫球蛋白水平似乎有益。免疫球蛋白缺乏是与感染频率、严重程度和模式相关性最好的因素。早期疾病有明显优势,早期诊断、定期通过免疫球蛋白水平和骨髓模式进行评估以及在疾病进展的首个证据出现时进行治疗可能具有益处。由于存在发生第二种肿瘤的可能性,对于新出现的症状应单独进行调查。

相似文献

1
Complications and causes of death in B cell chronic lymphocytic leukaemia: a long term study of 105 patients.B细胞慢性淋巴细胞白血病的并发症及死亡原因:105例患者的长期研究
Aust N Z J Med. 1990 Feb;20(1):44-50. doi: 10.1111/j.1445-5994.1990.tb00370.x.
2
[Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].[绝对单核细胞计数在慢性淋巴细胞白血病中的预后价值]
Orv Hetil. 2015 Apr;156(15):592-7. doi: 10.1556/OH.2015.30126.
3
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.免疫球蛋白VH基因突变状态及其他预后因素对慢性淋巴细胞白血病患者严重感染发生率的影响。
Cancer. 2006 Sep 1;107(5):1023-33. doi: 10.1002/cncr.22094.
4
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.慢性淋巴细胞白血病的预后因素:年龄、性别及治疗反应对生存的重要性。医学研究委员会慢性淋巴细胞白血病1号试验报告。医学研究委员会成人白血病工作组
Br J Haematol. 1989 Jun;72(2):141-9. doi: 10.1111/j.1365-2141.1989.tb07674.x.
5
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Venetoclax 治疗伴有 17p 缺失的复发或难治性慢性淋巴细胞白血病:一项多中心、开放标签、2 期研究。
Lancet Oncol. 2016 Jun;17(6):768-778. doi: 10.1016/S1470-2045(16)30019-5. Epub 2016 May 10.
6
Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.年轻成人早期/中期慢性淋巴细胞白血病(B-CLL)的预后特征与生存情况:一项单机构研究
Leukemia. 1993 Aug;7(8):1232-5.
7
Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia.
Br J Haematol. 1990 Sep;76(1):45-57. doi: 10.1111/j.1365-2141.1990.tb07835.x.
8
Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.氟达拉滨难治性B细胞慢性淋巴细胞白血病和小淋巴细胞淋巴瘤中严重感染的频率和类型:对该患者群体临床试验的影响
Cancer. 2002 Apr 1;94(7):2033-9.
9
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.国际慢性淋巴细胞白血病预后指数(CLL-IPI):个体患者数据的荟萃分析。
Lancet Oncol. 2016 Jun;17(6):779-790. doi: 10.1016/S1470-2045(16)30029-8. Epub 2016 May 13.
10
The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma.
Am J Hematol. 1999 Dec;62(4):208-11. doi: 10.1002/(sici)1096-8652(199912)62:4<208::aid-ajh2>3.0.co;2-e.

引用本文的文献

1
Neutrophils unveiled in chronic lymphocytic leukemia.慢性淋巴细胞白血病中发现的中性粒细胞。
Front Immunol. 2025 Aug 20;16:1609754. doi: 10.3389/fimmu.2025.1609754. eCollection 2025.
2
Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade.基于治疗和分子因素的加拿大大型集中性 CLL 临床十年预后分析。
Curr Oncol. 2023 Jul 5;30(7):6411-6431. doi: 10.3390/curroncol30070472.
3
Infections in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者的感染
Hematol Transfus Cell Ther. 2023 Jul-Sep;45(3):387-393. doi: 10.1016/j.htct.2023.05.006. Epub 2023 Jul 1.
4
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.CXCR4-STAT3-IL-10通路控制慢性淋巴细胞白血病的免疫调节功能并受来那度胺调节。
Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017.
5
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.血清球蛋白作为大剂量利妥昔单抗治疗慢性淋巴细胞白血病后免疫恢复的标志物。
Med Oncol. 2008;25(3):309-14. doi: 10.1007/s12032-007-9037-8. Epub 2008 Jan 5.
6
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.新型促凋亡药物R-依托度酸治疗B细胞慢性淋巴细胞白血病患者的I期研究
Invest New Drugs. 2008 Apr;26(2):139-49. doi: 10.1007/s10637-007-9106-z. Epub 2007 Dec 20.
7
Chronic lymphocytic leukaemia at a county hospital in southern Sweden.瑞典南部一家县级医院的慢性淋巴细胞白血病
Med Oncol. 1996 Jun;13(2):95-101. doi: 10.1007/BF02993859.